Flagship Harbor Advisors’s VanEck Biotech ETF BBH Stock Holding History
Bought
Maintained
Sold
Other funds holding BBH
MIM
CCA
BFG
Flagship Harbor Advisors's BBH Position: Q2 2026 in Review
Flagship Harbor Advisors increased its VanEck Biotech ETF (BBH) stake by 6.8% in Q2 2026, buying an estimated $30.1K and bringing the position to 2,509 shares worth $510K. The position accounts for 0.02% of the portfolio, ranked #514.
Flagship Harbor Advisors first reported a position in BBH in Q2 2018 and has held it in 19 quarters since. 110 funds tracked by Wall St. Rank hold BBH as of Q2 2026.
- Flagship Harbor Advisors held 2,509 shares of VanEck Biotech ETF worth $510K as of Q2 2026.
- Flagship Harbor Advisors bought 160 VanEck Biotech ETF shares in Q2 2026, an estimated $30.1K.
- VanEck Biotech ETF made up 0.02% of Flagship Harbor Advisors's portfolio in Q2 2026, its #514 holding.
- Flagship Harbor Advisors first reported a position in VanEck Biotech ETF in Q2 2018 and has held it in 19 quarters since.
- 110 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q2 2026.
Based on Flagship Harbor Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.